{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:29:12Z","timestamp":1788863352345,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejso.2022.04.018","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T11:47:56Z","timestamp":1651060076000},"page":"1972-1979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0271-3296","authenticated-orcid":false,"given":"Ting-Ying","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4423-4231","authenticated-orcid":false,"given":"Chih-Hsiung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Lung","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Shiou","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Chuan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.04.018_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2022.04.018_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00464-011-1933-5","article-title":"Completely laparoscopic versus open gastrectomy for early and advanced gastric cancer: a matched cohort study","volume":"26","author":"Moisan","year":"2012","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ejso.2022.04.018_bib3","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.surg.2015.11.002","article-title":"Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection","volume":"159","author":"Lee","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2022.04.018_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mehy.2018.02.023","article-title":"Preoperative gastric lavage in gastric cancer patients undergoing surgical, endoscopic or minimally invasive treatment: an oncological measure preventing peritoneal spillage of intragastric cancer cells and development of related metastases","volume":"114","author":"Virgilio","year":"2018","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ejso.2022.04.018_bib5","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/01.sla.0000143245.28656.15","article-title":"Patterns of initial recurrence in completely resected gastric adenocarcinoma","volume":"240","author":"D'Angelica","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.04.018_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12957-016-1042-y","article-title":"The patterns and timing of recurrence after curative resection for gastric cancer in China","volume":"14","author":"Liu","year":"2016","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.04.018_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jamcollsurg.2014.03.062","article-title":"Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis","volume":"219","author":"Spolverato","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2022.04.018_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000290955","article-title":"Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for malignant ascites due to advanced gastric cancer","volume":"78","author":"Kitayama","year":"2010","journal-title":"Oncology"},{"key":"10.1016\/j.ejso.2022.04.018_bib9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2022.04.018_bib10","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.04.018_bib11","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.04.018_bib12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ejso.2015.08.172","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: a systematic review and meta-analysis","volume":"41","author":"Huo","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.04.018_bib13","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.04.018_bib14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejca.2013.09.024","article-title":"Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases","volume":"50","author":"Elias","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2022.04.018_bib15","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (cyto-CHIP study): a propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.04.018_bib16","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1186\/s12885-019-6125-z","article-title":"Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study","volume":"19","author":"Beeharry","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2022.04.018_bib17","article-title":"Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer-A systematic review","volume":"8","author":"Brenkman","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ejso.2022.04.018_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2407-14-183","article-title":"GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study","volume":"14","author":"Glehen","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2022.04.018_bib19","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1245\/s10434-010-1362-z","article-title":"7th edition of the AJCC cancer staging manual: stomach","volume":"17","author":"Washington","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.04.018_bib20","first-page":"1181","article-title":"Prognostic factors and recurrence patterns in T4 gastric cancer patients after curative resection","volume":"10","author":"Zhu","year":"2019","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.ejso.2022.04.018_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0039-6060(99)70003-6","article-title":"No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer","volume":"125","author":"Hayashi","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2022.04.018_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(99)92164-5","article-title":"Blood dissemination of colonic epithelial cells during no-touch surgery for rectosigmoid cancer","volume":"354","author":"Sales","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2022.04.018_bib23","first-page":"343","article-title":"Dissemination of tumor cells in patients undergoing surgery for colorectal cancer","volume":"4","author":"Weitz","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2022.04.018_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ags3.12060","article-title":"Treatment of patients with peritoneal metastases from gastric cancer","volume":"2","author":"Kitayama","year":"2018","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.ejso.2022.04.018_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","article-title":"The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer","volume":"79","author":"Desiderio","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2022.04.018_bib26","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1245\/s10434-016-5738-6","article-title":"Prognostic factors and significance of gastrointestinal leak after cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC)","volume":"24","author":"Chouliaras","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.04.018_bib27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00423-019-01808-8","article-title":"Re-operations for early postoperative complications after CRS and HIPEC: indication, timing, procedure, and outcome","volume":"404","author":"Blaj","year":"2019","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.ejso.2022.04.018_bib28","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.7314\/APJCP.2012.13.9.4379","article-title":"Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis","volume":"13","author":"Huang","year":"2012","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.ejso.2022.04.018_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/02656736.2013.768359","article-title":"Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials","volume":"29","author":"Mi","year":"2013","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2022.04.018_bib30","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.humpath.2013.12.020","article-title":"Cthrc1 overexpression is an independent prognostic marker in gastric cancer","volume":"45","author":"Gu","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2022.04.018_bib31","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.3802\/jgo.2019.30.e84","article-title":"Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study","volume":"30","author":"\u00d8rtoft","year":"2019","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ejso.2022.04.018_bib32","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.12998\/wjcc.v7.i20.3247","article-title":"Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: a systemic review and meta-analysis","volume":"7","author":"Zheng","year":"2019","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.ejso.2022.04.018_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12885-018-4057-7","article-title":"A\u00a0retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites","volume":"18","author":"Matsumoto","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2022.04.018_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10120-012-0143-8","article-title":"Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasis","volume":"16","author":"Shitara","year":"2013","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2022.04.018_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0002-9610(99)00162-2","article-title":"Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma","volume":"178","author":"Bando","year":"1999","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2022.04.018_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejso.2013.10.019","article-title":"Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials","volume":"40","author":"Coccolini","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2022.04.018_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10120-011-0071-z","article-title":"A\u00a0systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer","volume":"15","author":"Leake","year":"2012","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2022.04.018_bib38","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","article-title":"Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC Trial","volume":"36","author":"Ishigami","year":"2018","journal-title":"J\u00a0Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322004139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322004139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:43:28Z","timestamp":1760060608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322004139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0748798322004139"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.04.018","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}